Previous Issue
Volume 3, March
 
 

J. Respir., Volume 3, Issue 2 (June 2023) – 5 articles

  • Issues are regarded as officially published after their release is announced to the table of contents alert mailing list.
  • You may sign up for e-mail alerts to receive table of contents of newly released issues.
  • PDF is the official format for papers published in both, html and pdf forms. To view the papers in pdf format, click on the "PDF Full-text" link, and use the free Adobe Readerexternal link to open them.
Order results
Result details
Select all
Export citation of selected articles as:
Review
The Role of Leukemia Inhibitory Factor in Counteracting the Immunopathology of Acute and Chronic Lung Inflammatory Diseases
J. Respir. 2023, 3(2), 86-100; https://doi.org/10.3390/jor3020009 - 07 Jun 2023
Abstract
Leukemia inhibitory factor (LIF), a member of the IL-6 cytokine family, is highly expressed throughout the body in multiple tissues and cell types. LIF is primarily known to induce the differentiation of myeloid leukemia cells, but recent studies show that LIF has many [...] Read more.
Leukemia inhibitory factor (LIF), a member of the IL-6 cytokine family, is highly expressed throughout the body in multiple tissues and cell types. LIF is primarily known to induce the differentiation of myeloid leukemia cells, but recent studies show that LIF has many other functions, including playing multiple roles in cancer and normal physiology. LIF expression is linked to cellular proliferation, metastasis, inflammation, and chemoresistance. LIF expression and secretion are triggered by many means and its downstream signaling can vary based on tissue types. Recent publications suggest that LIF may play a role in pulmonary diseases and its regulation is altered through external factors, such as cigarette smoke, inflammation stimuli, or infections. This review outlines the current knowledge of the function of LIF protein, mediators of LIF expression, receptors it interacts with, downstream LIF signaling, and possible pulmonary outcomes mediated by LIF. Full article
Show Figures

Figure 1

Article
Obstructive Sleep Apnea Is Associated with an Increased Risk of Developing Gastroesophageal Reflux Disease and Its Complications
J. Respir. 2023, 3(2), 75-85; https://doi.org/10.3390/jor3020008 - 05 Jun 2023
Viewed by 141
Abstract
Patients with obstructive sleep apnea (OSA) commonly report gastroesophageal reflux disease (GERD) symptoms, and limited data suggest a relationship between OSA and GERD-related complications. To investigate this association, we performed a population-based analysis using National Inpatient Sample (NIS) data for 7,159,694 patients. After [...] Read more.
Patients with obstructive sleep apnea (OSA) commonly report gastroesophageal reflux disease (GERD) symptoms, and limited data suggest a relationship between OSA and GERD-related complications. To investigate this association, we performed a population-based analysis using National Inpatient Sample (NIS) data for 7,159,694 patients. After adjusting for risk factors, OSA patients had a significantly higher incidence of GERD (32.3%) compared to those without OSA (15.0%, p < 0.01). OSA patients also had a higher risk of developing GERD-related complications, including non-erosive esophagitis, erosive esophagitis, esophageal stricture, and Barrett’s esophagus with and without dysplasia. Therefore, our results emphasize the importance of early detection and management of GERD and its complications in patients with OSA, particularly those with additional risk factors such as obesity and smoking. Full article
(This article belongs to the Collection Feature Papers in Journal of Respiration)
Show Figures

Figure 1

Systematic Review
Bidirectional Association between Psoriasis and Asthma: A Systematic Review and Meta-Analysis
J. Respir. 2023, 3(2), 60-74; https://doi.org/10.3390/jor3020007 - 19 May 2023
Viewed by 400
Abstract
Background: Studies have shown an increased risk of asthma in patients with psoriasis and vice versa. Thus, we conducted a meta-analysis to estimate the pooled association between these two chronic inflammatory diseases. Methods: A systematic search of the literature was conducted through March [...] Read more.
Background: Studies have shown an increased risk of asthma in patients with psoriasis and vice versa. Thus, we conducted a meta-analysis to estimate the pooled association between these two chronic inflammatory diseases. Methods: A systematic search of the literature was conducted through March 2023. Risk ratios (RRs) and prevalence were calculated. Results: A total of 11 studies comprising 110,978 patients with psoriasis and 1,898,071 controls were included in the first meta-analysis. The prevalence of asthma in patients with psoriasis was 9.2% (0.075, 0.110), and the pooled risk ratio (RR) was 1.43 (1.23,1.66). Subgroup analysis showed that older patients (≥50 years) have a higher pooled risk of asthma [RR 1.59 (1.41, 1.79)] than younger patients (20–49 years) [RR 1.23 (1.07,1.41)]. In addition, a significantly higher risk of asthma was seen in patients with moderate to severe psoriasis [RR 1.48 (1.17, 1.88)) when compared to their controls than those with mild psoriasis [RR 1.28 (1.14, 1.44)]. A total of 3 studies comprising 468,869 asthma patients and 11,063,349 control were included in the second meta-analysis. The prevalence of psoriasis in asthma patients was 1.3%, 0.004, 0.029), and the pooled risk ratio was 1.23 (1.02,1.47). Conclusions: This meta-analysis provides clear evidence for the bidirectional association between asthma and psoriasis. Full article
Show Figures

Figure 1

Review
Dust Exposure and Respiratory Health among Selected Factories in Ethiopia: Existing Evidence, Current Gaps and Future Directions
J. Respir. 2023, 3(2), 49-59; https://doi.org/10.3390/jor3020006 - 04 May 2023
Viewed by 651
Abstract
Workers who are working in dusty environments might be associated with respiratory health problems. In Ethiopia, factories processing wood, textile, coffee, flour, cement and other materials are associated with dust emission. Furthermore, despite the adoption of the International Labor Organization (ILO) convention, the [...] Read more.
Workers who are working in dusty environments might be associated with respiratory health problems. In Ethiopia, factories processing wood, textile, coffee, flour, cement and other materials are associated with dust emission. Furthermore, despite the adoption of the International Labor Organization (ILO) convention, the available constitution and labor proclamation, there are a lot of gaps in terms of occupational health and safety measures in Ethiopia. The current review aims to examine the existing evidence, current challenges and future direction regarding dust exposure and respiratory health in selected Ethiopian factories. Searches of peer-reviewed articles with full-length papers were made in online databases such as PubMed, Web of Science, MEDLINE, EMBASE and Google Scholar with a key words “Dust exposure”, “Respiratory health”, “Respiratory symptom”, “Ethiopia” and “Factory workers” from January 2000 to March 2023. The review found that excessive dust exposure is associated with a high prevalence of respiratory health problems. Lack of personal protective equipment and absence of safety and health training were the main occupational health deficits identified in most factories. Actions that focus on these deficiencies are commendable. Interventions focused on safety and health trainings, and the provision of adequate personal protective equipment of the required quality is recommended. In addition, administrative solutions and longitudinal studies on dust exposure and respiratory health are suggested. Full article
Article
Invasive Mechanical Ventilation and Death Was More Likely in Patients with Lower LDL Cholesterol Levels during COVID-19 Hospitalization: A Retrospective Propensity-Matched Cohort Study
J. Respir. 2023, 3(2), 39-48; https://doi.org/10.3390/jor3020005 - 02 Apr 2023
Viewed by 778
Abstract
Hyperlipidemia has been associated with worse outcomes in patients with Coronavirus disease 2019 (COVID-19). However, lower LDL-C (low-density lipoprotein cholesterol) levels have been associated with increased COVID-19 severity and mortality. We conducted a retrospective observational study of patients with COVID-19 admitted to New [...] Read more.
Hyperlipidemia has been associated with worse outcomes in patients with Coronavirus disease 2019 (COVID-19). However, lower LDL-C (low-density lipoprotein cholesterol) levels have been associated with increased COVID-19 severity and mortality. We conducted a retrospective observational study of patients with COVID-19 admitted to New York City Health and Hospitals from 1 March 2020 to 31 October 2020, comparing pre-COVID-19 LDL-C levels or LDL-C levels obtained during COVID-19 hospitalization, with the need for invasive mechanical ventilation and death. Propensity score matching was performed using logistic regression models, and standardized mean differences were calculated. A total of 3020 patients (median age 61 years; 36% women) were included. In the matched cohort, on multivariate logistic regression analysis, LDL was inversely associated with in-hospital death (OR: 0.99, 95% CI: 0.986–0.999, p = 0.036). As a categorical variable, LDL > 70 mg/dL was associated with 47% lower likelihood of invasive mechanical ventilation (OR: 0.53, 95% CI: 0.29–0.95, p = 0.034). No significant association between pre-COVID-19 LDL and death or invasive mechanical ventilation was found (OR: 1.00, 95% CI 0.99–1.01, p = 0.833). Low LDL-C level measured during COVID-19 was associated with a higher likelihood of invasive mechanical ventilation and in-hospital death. A similar association was not found between pre-COVID-19 LDL-C and these outcomes. LDL-C levels obtained during COVID-19 are likely not reflective of the baseline lipid profile. Full article
Show Figures

Figure 1

Previous Issue
Back to TopTop